logo
Select company
Select metric
-13091.1%Operating Cash Flow Margin
VS
Market
1
Sector
4
Industry
8
History
13
$ 4.81Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information

Ticker

ADVM

Company Name

ADVERUM BIOTECHNOLOGIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADVERUM BIOTECHNOLOGIES INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADVM - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -130.91M-13091.1%$ 1M
3/31/2025$ -111.99M-11198.8%$ 1M
12/31/2024$ -92.46M-9246.2%$ 1M
9/30/2024$ -85.54M-8554.1%$ 1M
6/30/2024$ -88.33M0%$ 0
3/31/2024$ -91.73M0%$ 0
12/31/2023$ -90.9M-2525.06%$ 3.6M
9/30/2023$ -88.05M-2445.81%$ 3.6M
6/30/2023$ -95.94M-2665.11%$ 3.6M
3/31/2023$ -101.57M-2821.5%$ 3.6M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average OCF % has been -4829.02%.
  • The median OCF % for ADVERUM BIOTECHNOLOGIES INC during this period was -2595.08%
  • ADVERUM BIOTECHNOLOGIES INC reached its highest OCF % over the past 5 years at -1173.07%.
  • The lowest OCF % recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe -13091.1%

ADVERUM BIOTECHNOLOGIES INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
DTIL : PRECISION BIOSCIENCES INC -5068.83%RANI : RANI THERAPEUTICS HOLDINGS INC -2584.17%RNXT : RENOVORX INC -1556.95%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1031.07%PLUR : PLURI INC -1363.1%LSTA : LISATA THERAPEUTICS INC -1533.08%IGC : IGC PHARMA INC -335.34%CLSD : CLEARSIDE BIOMEDICAL INC -1616.52%COEP : COEPTIS THERAPEUTICS HOLDINGS INC -3070.35%RLYB : RALLYBIO CORP -5517.87%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: CF - Operations [ $ -71.9M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

ADVM - Operating Cash Flow Margin, Last 5 years

-13091.1%

Minimum

Jun 30, 2025

-1173.07%

Maximum

Mar 31, 2021

-4829.02%

Average

-2595.08%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%